This paper is in the following e-collection/theme issue:

mHealth for Treatment Adherence (384) mHealth for Treatment Adherence (384) Chronic Disease Self-Management in Childhood and Adolescence (123)

Published on in Vol 7, No 8 (2019): August

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/13452, first published .
A Multidimensional Electronic Hydroxyurea Adherence Intervention for Children With Sickle Cell Disease: Single-Arm Before-After Study

A Multidimensional Electronic Hydroxyurea Adherence Intervention for Children With Sickle Cell Disease: Single-Arm Before-After Study

A Multidimensional Electronic Hydroxyurea Adherence Intervention for Children With Sickle Cell Disease: Single-Arm Before-After Study

Authors of this article:

Susan Creary1 Author Orcid Image ;   Deena Chisolm1 Author Orcid Image ;   Joseph Stanek1 Author Orcid Image ;   Jane Hankins2 Author Orcid Image ;   Sarah H O'Brien1 Author Orcid Image
Article Authors Cited by (15) Tweetations (3) Metrics

Journals

  1. Alberts N, Badawy S, Hodges J, Estepp J, Nwosu C, Khan H, Smeltzer M, Homayouni R, Norell S, Klesges L, Porter J, Hankins J. Development of the InCharge Health Mobile App to Improve Adherence to Hydroxyurea in Patients With Sickle Cell Disease: User-Centered Design Approach. JMIR mHealth and uHealth 2020;8(5):e14884 View
  2. Hankins J, Shah N, DiMartino L, Brambilla D, Fernandez M, Gibson R, Gordeuk V, Lottenberg R, Kutlar A, Melvin C, Simon J, Wun T, Treadwell M, Calhoun C, Baumann A, Potter M, Klesges L, Bosworth H. Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Efficacy and Implementation Study. JMIR Research Protocols 2020;9(7):e16319 View
  3. Creary S, Chisolm D, Stanek J, Neville K, Garg U, Hankins J, O'Brien S. Measuring hydroxyurea adherence by pharmacy and laboratory data compared with video observation in children with sickle cell disease. Pediatric Blood & Cancer 2020;67(8) View
  4. Eaton C, Comer M, Pruette C, Psoter K, Riekert K. Text Messaging Adherence Intervention for Adolescents and Young Adults with Chronic Kidney Disease: Pilot Randomized Controlled Trial and Stakeholder Interviews. Journal of Medical Internet Research 2020;22(8):e19861 View
  5. Morse R, Myburgh H, Reubi D, Archey A, Busakwe L, Garcia-Prats A, Hesseling A, Jacobs S, Mbaba S, Meyerson K, Seddon J, van der Zalm M, Wademan D, Hoddinott G. Opportunities for Mobile App–Based Adherence Support for Children With Tuberculosis in South Africa. JMIR mHealth and uHealth 2020;8(11):e19154 View
  6. Ingerski L, Loew M, Porter J, Su Y, Zhang H, Hankins J, Wang W. Use of Wise Device Technology to Measure Adherence to Hydroxyurea Therapy in Youth With Sickle Cell Disease. Journal of Pediatric Hematology/Oncology 2021;43(1):e19 View
  7. Phillips S, Kanter J, Mueller M, Gulledge A, Ruggiero K, Johnson M, Kelechi T. Feasibility of an mHealth self-management intervention for children and adolescents with sickle cell disease and their families. Translational Behavioral Medicine 2021;11(3):724 View
  8. Badawy S, Cronin R, Liem R, Palermo T. Digital behavioural interventions for people with sickle cell disease. Cochrane Database of Systematic Reviews 2021 View
  9. Creary S, Beeman C, Stanek J, King K, McGann P, O'Brien S, Liem R, Holl J, Badawy S. Impact of hydroxyurea dose and adherence on hematologic outcomes for children with sickle cell anemia. Pediatric Blood & Cancer 2022;69(6) View
  10. Janson I, Bloom E, Hampton K, Meier E, Rampersad A, Kronenberger W. Development and Validation of the Patient/Caregiver Reported Hydroxyurea Evaluation of Adherence for Life (HEAL) Scale. Patient Preference and Adherence 2022;Volume 16:3229 View
  11. Stasher-Booker B, Stapleton D, M. Raines G. The Use of Smartphone Technology to Improve the Health of Sickle Cell Patients. Journal of Public Health Issues and Practices 2021;5(2) View
  12. Reeves S, Peng H, Wing J, Cogan L, Goel A, Anders D, Green N, Lisabeth L, Dombkowski K. Changes in Hydroxyurea Use Among Youths Enrolled in Medicaid With Sickle Cell Anemia After 2014 Revision of Clinical Guidelines. JAMA Network Open 2023;6(3):e234584 View
  13. Reeves S, Dombkowski K, Peng H, Phan H, Kolenic G, Creary S, Madden B, Lisabeth L. Adherence to hydroxyurea and clinical outcomes among children with sickle cell anemia. Pediatric Blood & Cancer 2023;70(7) View
  14. Green N, Manwani D, Aygun B, Appiah‐Kubi A, Smith‐Whitley K, Castillo Y, Soriano L, Jia H, Smaldone A. Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment (HABIT) efficacy trial: Community health worker support may increase hydroxyurea adherence of youth with sickle cell disease. Pediatric Blood & Cancer 2024;71(4) View
  15. Walden J, Brown L, Seiguer S, Munshaw K, Rausch J, Badawy S, McGann P, Winkler S, Gonzalez L, Creary S, Tucker J. Study protocol for ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness): Using small business partnerships to deliver a scalable and novel hydroxyurea adherence solution to youth with sickle cell disease. PLOS ONE 2024;19(6):e0304644 View